GxP Lifeline Blood & Biologics Publication Click to visit GxP Lifeline Home Click to visit mastercontrol.com

Featured Articles

April 2010

Stay Ahead of the FDA: Process Mapping, Gap Analysis and SOP Review

Kerry Potter

What happens when the FDA arrives at your manufacturing facility? Your first reaction may be panic or perhaps regret for not having solved any wayward problems the inspection team will surely now find. But it does not have to be that way. In fact, by preparing in advance and using the right tools, a firm should be able to greet the FDA by saying, "Excellent. Everyone knows what to do. Let's get right to it." That is the exact attitude companies need to successfully pass any inspection.

Read more


Improving Data and Content Migration Testing: A Top Ten for Getting Data and Content Migration Testing on the Right Track

David Katzoff

Traditionally, migrations have been tested using some form of post-migration testing, often limited to sampling. While this certainly has a role for some migrations, it starts relatively late in the overall process, is labor intensive, and misses many data-level errors. These limitations particularly come into play in highly regulated companies where the required margins of error are not feasible.

This article introduces a broad set of data migration testing techniques beginning with pre-migration testing. These techniques are all well established and offer a number of benefits. After a review of these techniques, a set of "top ten" recommendations are provided for the design of an appropriate migration testing strategy.

Read more


Change Control: Continuous Quality Improvement in FDA and ISO Environments

Jason Clegg

Globalization of the marketplace has greatly intensified competition. It has increased the pressure on manufacturers to develop innovative, high-quality products faster and at a lower cost. To stay competitive, manufacturers must be quick to meet customer demands and even quicker in adapting to changing market conditions.

The situation could not be more acute than in the FDA and ISO environments, where manufacturers must contend not only with cutthroat competition and a dynamic market, but also stringent regulatory requirements. Consider the fiercely competitive pharmaceutical industry. Only one of every 10,000 potential medicines investigated by American research- based pharmaceutical companies makes it through the rigorous FDA approval process, according to the Pharmaceutical Research and Manufacturers of America. It takes about 15 years at a cost of more than $800 million before a new medicine is approved.

Read more


 

Featured Webinar:

Featured White Paper:

Previous Newsletters:

Watch Customer Videos

View Upcoming Events

Did You Know?

Quality Event Management CAPA Training
April 14-15, 2010, Boston, MA

World Conference on Quality and Improvement
May 24-26, 2010, St. Louis, MO

AOPO
June 15-18, 2010, Baltimore, MD

AABB Conference
October 9, 2010, Baltimore, MD

View More Events

Did you know that supplier evaluations differ from audits in scope and in requirements? "What's the difference between a supplier evaluation and an audit, from FDA's point of view?" you might ask. Find out from EduQuest, a global team of compliance experts, what the main differences are and learn how to prepare for both.
Read More